Profilo
Cedric O'Gorman formerly worked at Axsome Therapeutics, Inc., as Senior VP-Clinical Development & Medical Affairs, Intra-Cellular Therapies, Inc., as Vice President-Medical Affairs from 2014 to 2017, Relmada Therapeutics, Inc., as Chief Medical Officer from 2023 to 2024, and Alpha Cognition, Inc., as Chief Medical Officer from 2021 to 2023.
Dr. O'Gorman received his doctorate degree from National University of Ireland and Masters Business Admin degree in 2010 from The Leonard N Stern School of Business.
Precedenti posizioni note di Cedric O'Gorman
| Società | Posizione | Fine |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 03/01/2024 |
| ALPHA COGNITION INC. | Direttore Tecnico/Scientifico/R&S | 06/01/2023 |
| AXSOME THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 02/12/2021 |
| INTRA-CELLULAR THERAPIES, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2017 |
Formazione di Cedric O'Gorman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
National University of Ireland
National University of Ireland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
















